Alice Bonneville-Levard
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Meningioma and schwannoma management, Cancer Genomics and Diagnostics, Brain Metastases and Treatment, Prostate Cancer Treatment and Research
Most-Cited Works
- → Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial(2019)183 cited
- → Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)(2021)73 cited
- → Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)(2017)52 cited
- → MEVITEM—a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation(2021)34 cited
- → Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer(2021)31 cited
- → Olaparib in recurrent IDH-mutant high-grade glioma (OLAGLI).(2021)23 cited
- → Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfiLER study.(2017)23 cited
- → Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias(2020)23 cited
- → Trabectedin for recurrent WHO grade II or III meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).(2019)19 cited
- → Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients(2020)15 cited